209 related articles for article (PubMed ID: 30026293)
1. Mutations in microRNA processing genes in Wilms tumors derepress the
Chen KS; Stroup EK; Budhipramono A; Rakheja D; Nichols-Vinueza D; Xu L; Stuart SH; Shukla AA; Fraire C; Mendell JT; Amatruda JF
Genes Dev; 2018 Aug; 32(15-16):996-1007. PubMed ID: 30026293
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
Wang WH; Duan JX; Vu TH; Hoffman AR
J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
[TBL] [Abstract][Full Text] [Related]
3. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
5. Overgrowth syndromes and pediatric cancers: how many roads lead to
Bharathavikru R; Hastie ND
Genes Dev; 2018 Aug; 32(15-16):993-995. PubMed ID: 30068702
[TBL] [Abstract][Full Text] [Related]
6. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic adenoma gene1 in reproduction and implication for embryonic survival in cattle: a review.
D'Occhio MJ; Campanile G; Baruselli PS; Porto Neto LR; Hayes BJ; Snr AC; Fortes MRS
J Anim Sci; 2024 Jan; 102():. PubMed ID: 38586898
[TBL] [Abstract][Full Text] [Related]
8. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation.
Huang L; Mokkapati S; Hu Q; Ruteshouser EC; Hicks MJ; Huff V
Neoplasia; 2016 Feb; 18(2):71-81. PubMed ID: 26936393
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Igf and Wnt signalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice.
Declercq J; Van Dyck F; Van Damme B; Van de Ven WJ
Int J Oncol; 2008 May; 32(5):1041-7. PubMed ID: 18425330
[TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
[TBL] [Abstract][Full Text] [Related]
11. Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice.
Zhao X; Ren W; Yang W; Wang Y; Kong H; Wang L; Yan L; Xu G; Fei J; Fu J; Zhang C; Wang Z
Int J Cancer; 2006 Feb; 118(3):643-8. PubMed ID: 16108035
[TBL] [Abstract][Full Text] [Related]
12. [Molecular techniques lead to the first insights into the pathophysiology of salivary gland adenomas].
Kas K
Verh K Acad Geneeskd Belg; 2001; 63(1):35-40. PubMed ID: 11284386
[TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
14. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
[TBL] [Abstract][Full Text] [Related]
15. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation.
Hu Q; Gao F; Tian W; Ruteshouser EC; Wang Y; Lazar A; Stewart J; Strong LC; Behringer RR; Huff V
J Clin Invest; 2011 Jan; 121(1):174-83. PubMed ID: 21123950
[TBL] [Abstract][Full Text] [Related]
16. PLAG1 silencing promotes cell chemosensitivity in ovarian cancer via the IGF2 signaling pathway.
Huang W; Li BR; Feng H
Int J Mol Med; 2020 Mar; 45(3):703-714. PubMed ID: 31922228
[TBL] [Abstract][Full Text] [Related]
17. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
19. Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma.
Yu C; Li J; Sun F; Cui J; Fang H; Sui G
Med Sci Monit; 2016 Dec; 22():5101-5108. PubMed ID: 28012286
[TBL] [Abstract][Full Text] [Related]
20. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F
Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
